Comparison
Companies and funds side by side across all metrics. The best value in each row is highlighted.
Performance from the same starting point
All series start at 100 on the same day. The price is adjusted for dividends.
Green background = the best value in the row (the lowest one for cost metrics).
| Loading… |
Compared securities
- Monopar Therapeutics Inc. (MNPR): price 71,06 USD, market cap 488 mil. USD
- Kazia Therapeutics Limited (KZIA): price 5,310 USD, market cap 87,1 mil. USD